The company will save about $130 million in 2024-25 as it eliminates 176 roles.
Tag Archive for: cancer cell therapy
AstraZeneca and Neogene have entered into a definitive acquisition agreement in which AstraZeneca will buy all outstanding equity in the smaller company for $320 million.
